Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07202598

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also known as Autoimmune polyendocrine syndrome type-1 (APS-1), is a disea…

United States10 participantsStarted 2025-11-12

Treatment: Emapalumab

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

All recent trials (1 shown)